Weifang Shengtai Pharmaceutical, Inc. (SGTI.OB) to Supply 10,000 Tons of Dextrose Monohydrate Inject Grade to Kelun Pharmaceutical
One company that is starting to earn a global presence is Weifang Shengtai Pharmaceutical, Inc. Located in Weifang, China, the young company is a subsidiary of Shengtai Pharmaceutical and a leading producer of pharmaceutical injection-grade glucose in China. Today, the parent company announced they have entered into a major agreement with the renowned Chinese company Kelun Pharmaceutical. The agreement will supply Kelun 10,000 tons of dextrose monohydrate injection grade. Subsidiaries of Kelun will also benefit with Kelun Guizhou being supplied 700 tons and Kelun Sichuan 9,300 tons. The agreement will be carried out by prepayments and was entered into at…